MIRANDA CROWELL: Open Payments
NPI 1003556077 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 47 payments from 11 companies in 2025. Trend: 2023 $154 · 2024 $1,135 · 2025 $1,205
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $276 |
| ABBVIE INC. | 6 | $207 |
| Supernus Pharmaceuticals, Inc. | 7 | $188 |
| Neurocrine BioSciences, Inc. | 5 | $124 |
| Corium, LLC | 7 | $107 |
| Otsuka America Pharmaceutical, Inc. | 5 | $95 |
| Axsome Therapeutics, Inc. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: VRAYLAR, Qelbree, ARISTADA, LYBALVI, INGREZZA, Azstarys, Auvelity, AUSTEDO XR.
Industry payments across AL — which companies pay providers there.
